Pricing Log in Create free account

PainReform Ltd. (PRFX) vs China SXT Pharmaceuticals, Inc. (SXTC)

PainReform Ltd. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. is the larger, with a market value of $2.3M against $2.0M — 1.1× the size. PainReform Ltd. has the higher net margin (0.00% vs −255.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, PainReform Ltd. leads on 5 and China SXT Pharmaceuticals, Inc. on 4.

Valuation

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m n/m 2.08
P/B 0.00 n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 0.97 2.66 12.22
EV/Sales n/m (5.94) 2.87
Earnings yield (156,798.70%) (3,722.74%) (15.94%)
Free cash flow yield (101,853.01%) 0.00% 0.00%

Profitability

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 36.69% 53.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (255.16%) (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.80%)
Return on assets 0.00% 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (53.98%) 5.22%
EPS growth (last fiscal year) 92.92% (162.25%) 42.91%
Revenue growth, 5-year CAGR — (24.94%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.03 0.04
Current ratio 5.07 7.94 2.41
Net debt to EBITDA 0.96 3.86 1.01

Dividend

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric PRFX SXTC Drug Manufacturers Specialty & Generic median
Market cap 2.31m 2.02m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack